Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury.
Papa S, Rossi F, Ferrari R, Mariani A, De Paola M, Caron I, Fiordaliso F, Bisighini C, Sammali E, Colombo C, Gobbi M, Canovi M, Lucchetti J, Peviani M, Morbidelli M, Forloni G, Perale G, Moscatelli D, Veglianese P. Papa S, et al. Among authors: canovi m. ACS Nano. 2013 Nov 26;7(11):9881-95. doi: 10.1021/nn4036014. Epub 2013 Oct 18. ACS Nano. 2013. PMID: 24138479
Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest.
Fumagalli F, Russo I, Staszewsky L, Li Y, Letizia T, Masson S, Novelli D, Rocchetti M, Canovi M, Veglianese P, Gobbi M, Latini R, Zaza A, Ristagno G. Fumagalli F, et al. Among authors: canovi m. Heart Rhythm. 2014 Sep;11(9):1641-7. doi: 10.1016/j.hrthm.2014.05.023. Epub 2014 May 22. Heart Rhythm. 2014. PMID: 24858811
PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.
Brambilla D, Verpillot R, Le Droumaguet B, Nicolas J, Taverna M, Kóňa J, Lettiero B, Hashemi SH, De Kimpe L, Canovi M, Gobbi M, Nicolas V, Scheper W, Moghimi SM, Tvaroška I, Couvreur P, Andrieux K. Brambilla D, et al. Among authors: canovi m. ACS Nano. 2012 Jul 24;6(7):5897-908. doi: 10.1021/nn300489k. Epub 2012 Jun 19. ACS Nano. 2012. PMID: 22686577
Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
Le Droumaguet B, Nicolas J, Brambilla D, Mura S, Maksimenko A, De Kimpe L, Salvati E, Zona C, Airoldi C, Canovi M, Gobbi M, Magali N, La Ferla B, Nicotra F, Scheper W, Flores O, Masserini M, Andrieux K, Couvreur P. Le Droumaguet B, et al. Among authors: canovi m. ACS Nano. 2012 Jul 24;6(7):5866-79. doi: 10.1021/nn3004372. Epub 2012 Jul 2. ACS Nano. 2012. PMID: 22725248
Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)δ-1 Subunit.
Senatore A, Colleoni S, Verderio C, Restelli E, Morini R, Condliffe SB, Bertani I, Mantovani S, Canovi M, Micotti E, Forloni G, Dolphin AC, Matteoli M, Gobbi M, Chiesa R. Senatore A, et al. Among authors: canovi m. Neuron. 2012 Apr 26;74(2):300-13. doi: 10.1016/j.neuron.2012.02.027. Neuron. 2012. PMID: 22542184 Free PMC article.
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.
Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, Cesaro P, Buffa C, Aucan C, Lucca U, Peckeu L, Suardi S, Tranchant C, Zerr I, Houillier C, Redaelli V, Vespignani H, Campanella A, Sellal F, Krasnianski A, Seilhean D, Heinemann U, Sedel F, Canovi M, Gobbi M, Di Fede G, Laplanche JL, Pocchiari M, Salmona M, Forloni G, Brandel JP, Tagliavini F. Haïk S, et al. Among authors: canovi m. Lancet Neurol. 2014 Feb;13(2):150-8. doi: 10.1016/S1474-4422(13)70307-7. Epub 2014 Jan 8. Lancet Neurol. 2014. PMID: 24411709 Clinical Trial.
23 results